EP 1222274 A2 20020717 - MAGE-A12 ANTIGENIC PEPTIDES AND USES THEREOF
Title (en)
MAGE-A12 ANTIGENIC PEPTIDES AND USES THEREOF
Title (de)
VOM MAGE-12 ABGELEITETE ANTIGENE PEPTIDE UND DEREN VERWENDUNGEN
Title (fr)
PEPTIDES ANTIGENIQUES MAGE-A12 ET UTILISATION
Publication
Application
Priority
- US 0028852 W 20001019
- US 16037499 P 19991019
- US 17957000 P 20000201
Abstract (en)
[origin: WO0129220A2] The invention provides antigenic peptides derived from MAGE-A12 polypeptides and presented by HLA molecules. Methods for diagnosis and treatment which involve the polypeptides also are provided.
IPC 1-7
C12N 15/12; C07K 14/47; A61K 38/17; G01N 33/53; C07K 16/18; C12N 5/06; A61K 39/00; A61K 35/14
IPC 8 full level
G01N 33/50 (2006.01); A61K 35/26 (2006.01); A61K 38/00 (2006.01); A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 48/00 (2006.01); A61P 35/00 (2006.01); C07K 14/47 (2006.01); C12N 1/15 (2006.01); C12N 1/19 (2006.01); C12N 1/21 (2006.01); C12N 5/07 (2010.01); C12N 5/071 (2010.01); C12N 5/10 (2006.01); C12N 15/09 (2006.01); C12N 15/12 (2006.01); C12P 21/08 (2006.01); C12Q 1/02 (2006.01); G01N 33/15 (2006.01); G01N 33/53 (2006.01); G01N 33/566 (2006.01); G01N 37/00 (2006.01)
CPC (source: EP KR)
A61P 35/00 (2017.12 - EP); C07K 14/47 (2013.01 - KR); C07K 14/4748 (2013.01 - EP); A61K 38/00 (2013.01 - EP); A61K 39/00 (2013.01 - EP KR); A61K 2039/5154 (2013.01 - EP KR)
Citation (search report)
See references of WO 0129220A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 0129220 A2 20010426; WO 0129220 A3 20020307; AU 1335601 A 20010430; CA 2386088 A1 20010426; CN 1402782 A 20030312; EP 1222274 A2 20020717; HK 1046925 A1 20030130; JP 2003512057 A 20030402; KR 20020047249 A 20020621
DOCDB simple family (application)
US 0028852 W 20001019; AU 1335601 A 20001019; CA 2386088 A 20001019; CN 00814604 A 20001019; EP 00975282 A 20001019; HK 02107155 A 20020927; JP 2001532203 A 20001019; KR 20027004975 A 20020418